专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20110145747A1 Structured Tailoring 审中-公开
标题翻译：结构化裁缝
公开(公告)号：US20110145747A1
公开(公告)日：2011-06-16
申请号：US12818930
申请日：2010-06-18
申请人： Daniel Wong , David Hasker , Glenn Brassington , Stefan Weinert , Abhishek S. Soni , Alan Greenburg , Paul J. Galley , Ulrich Porsch , Robert E. Reinke
发明人： Daniel Wong , David Hasker , Glenn Brassington , Stefan Weinert , Abhishek S. Soni , Alan Greenburg , Paul J. Galley , Ulrich Porsch , Robert E. Reinke
IPC分类号： G06F3/048 , G06F17/30 , G06F15/16
摘要： Embodiments related to a self-administered, behavior modification program facilitated through a structured tailoring method and system thereof which accelerates and enhances the internalization process of the individual, and which provides help when the individual begins to fail in adhering or continuing with the behavior modification are disclosed. Program instructions that when executed by a processor causes a processor to initiate automatically a schedule of events of a structured tailoring procedure upon entry criteria being met at some unknown time, provide intervention according to the intervention preferences when the adherence criteria for one of the events has not been met, and end automatically the structured collection procedure upon exit criteria being met at some unknown time.
摘要翻译：通过结构化的裁剪方法及其系统来促进自行管理的行为修改程序的实施方式，其加速和增强个人的内部化过程，并且当个人开始失败时坚持或继续行为修改时提供帮助披露当处理器执行时，程序指令使得处理器在某个未知时间满足入门标准时自动启动结构化定制过程的事件调度，当事件之一的遵守标准具有干预时，根据干预偏好提供干预没有被满足，并且在某些未知时间满足退出条件时自动结束收集过程。

2. 发明授权

US10456036B2 Structured tailoring 有权
公开(公告)号：US10456036B2
公开(公告)日：2019-10-29
申请号：US12818930
申请日：2010-06-18
申请人： Daniel Wong , David Hasker , Glenn Brassington , Stefan Weinert , Abhishek S. Soni , Alan Greenburg , Paul J. Galley , Ulrich Porsch , Robert E. Reinke , Marco De Polo
发明人： Daniel Wong , David Hasker , Glenn Brassington , Stefan Weinert , Abhishek S. Soni , Alan Greenburg , Paul J. Galley , Ulrich Porsch , Robert E. Reinke , Marco De Polo
IPC分类号： A61B5/00 , A61B5/145 , G06F19/00 , G06Q10/10 , G06Q50/22 , G16H10/20 , G16H40/63 , G16H50/20 , A61B5/021 , A61B5/024
摘要： Embodiments related to a self-administered, behavior modification program facilitated through a structured tailoring method and system thereof which accelerates and enhances the internalization process of the individual, and which provides help when the individual begins to fail in adhering or continuing with the behavior modification are disclosed. Program instructions that when executed by a processor causes a processor to initiate automatically a schedule of events of a structured tailoring procedure upon entry criteria being met at some unknown time, provide intervention according to the intervention preferences when the adherence criteria for one of the events has not been met, and end automatically the structured collection procedure upon exit criteria being met at some unknown time.

3. 发明申请

US20120173151A1 METHODS OF ASSESSING DIABETES TREATMENT PROTOCOLS BASED ON PROTOCOL COMPLEXITY LEVELS AND PATIENT PROFICIENCY LEVELS 审中-公开
标题翻译：基于协议复杂程度和患者专业水平评估糖尿病治疗协议的方法
公开(公告)号：US20120173151A1
公开(公告)日：2012-07-05
申请号：US12980652
申请日：2010-12-29
申请人： Paul J. Galley , Stefan Weinert , David Hasker , Ulrich Porsch
发明人： Paul J. Galley , Stefan Weinert , David Hasker , Ulrich Porsch
IPC分类号： G06F19/00
CPC分类号： G06F19/325 , G06F19/3456 , G06F19/3468 , G06Q10/063112
摘要： Embodiments of methods of assessing a diabetes treatment protocol comprise determining a protocol complexity level corresponding to a degree of difficulty of completing the diabetes treatment protocol by utilizing the processor, determining a patient proficiency level corresponding to a skill set of the patient in conducting the diabetes treatment protocol by utilizing the processor, comparing the protocol complexity level to the patient proficiency level via the processor, and providing an output based on the comparison.
摘要翻译：评估糖尿病治疗方案的方法的实施方案包括通过利用处理器确定对应于完成糖尿病治疗方案的难度的方案复杂度水平，确定与进行糖尿病治疗的患者的技能组相对应的患者熟练度水平通过利用处理器协议，通过处理器将协议复杂度水平与患者熟练程度进行比较，并且基于比较提供输出。

4. 发明申请

US20110015511A1 SYSTEMS AND METHODS FOR OPTIMIZING INSULIN DOSAGE 有权
标题翻译：用于优化胰岛素剂量的系统和方法
公开(公告)号：US20110015511A1
公开(公告)日：2011-01-20
申请号：US12818310
申请日：2010-06-18
申请人： Steven Bousamra , Stefan Weinert , Juergen Rasch-Menges , P. Douglas Walling , John F. Price , Heino Eikmeier , Birgit Kraeling , Karl Werner , Ulrich Porsch
发明人： Steven Bousamra , Stefan Weinert , Juergen Rasch-Menges , P. Douglas Walling , John F. Price , Heino Eikmeier , Birgit Kraeling , Karl Werner , Ulrich Porsch
IPC分类号： A61B5/145 , G06F19/00 , G01N33/48 , G09B23/28
CPC分类号： A61B5/0002 , A61B5/05 , A61B5/14532 , A61B5/14546 , A61M31/00 , A61M2230/201 , C12Q1/006 , G06F19/00 , G06F19/3418 , G06F19/3456 , G16H10/20 , G16H10/40 , G16H20/17 , G16H80/00
摘要： Embodiments of a testing method suitable for diabetic persons to optimize their administered insulin dosage comprise collecting one or more sampling sets of biomarker data, wherein each sampling set comprises a sufficient plurality of non-adverse sampling instances and wherein each sampling instance comprises an acceptable biomarker reading at a single point in time recorded upon compliance with adherence criteria, determining a biomarker sampling parameter from each sampling set, comparing the biomarker sampling parameter to a target biomarker range, calculating an insulin adjustment parameter associated with the biomarker sampling parameter if the biomarker sampling parameter falls outside the target biomarker range, adjusting the insulin dosage by the insulin adjustment parameter if the biomarker sampling parameter falls outside the target biomarker range and if the insulin dosage does not exceed maximum dosage, and exiting the testing method if the adjusted insulin dosage is optimized. The insulin dosage is optimized when one or more biomarker sampling parameters fall within a target biomarker range.
摘要翻译：适于糖尿病患者优化其施用的胰岛素剂量的测试方法的实施方案包括收集一个或多个生物标志物数据的采样组，其中每个采样组包括足够多个非不良采样实例，并且其中每个采样实例包括可接受的生物标志物读数在符合遵守标准的单个时间点上，从每个采样组确定生物标志物采样参数，将生物标志物采样参数与目标生物标志物范围进行比较，计算与生物标志物采样参数相关联的胰岛素调节参数，如果生物标志物采样参数如果生物标志物采样参数落在目标生物标志物范围之外，并且如果胰岛素剂量不超过最大剂量，并且如果调整的胰岛素剂量是最佳的则退出测试方法，则超出目标生物标志物范围，通过胰岛素调节参数调整胰岛素剂量 zed。当一个或多个生物标志物采样参数落入目标生物标志物范围内时，胰岛素剂量被优化。

5. 发明授权

US09918635B2 Systems and methods for optimizing insulin dosage 有权
公开(公告)号：US09918635B2
公开(公告)日：2018-03-20
申请号：US12818310
申请日：2010-06-18
申请人： Steven Bousamra , Stefan Weinert , Juergen Rasch-Menges , P. Douglas Walling , John F. Price , Heino Eikmeier , Birgit Kraeling , Karl Werner , Ulrich Porsch
发明人： Steven Bousamra , Stefan Weinert , Juergen Rasch-Menges , P. Douglas Walling , John F. Price , Heino Eikmeier , Birgit Kraeling , Karl Werner , Ulrich Porsch
IPC分类号： A61B5/00 , A61B5/145 , G06F19/00 , A61M31/00 , A61B5/05 , C12Q1/00
CPC分类号： A61B5/0002 , A61B5/05 , A61B5/14532 , A61B5/14546 , A61M31/00 , A61M2230/201 , C12Q1/006 , G06F19/00 , G06F19/3418 , G06F19/3456 , G16H10/20 , G16H10/40 , G16H20/17 , G16H80/00
摘要： Embodiments of a testing method suitable for diabetic persons to optimize their administered insulin dosage comprise collecting one or more sampling sets of biomarker data, wherein each sampling set comprises a sufficient plurality of non-adverse sampling instances and wherein each sampling instance comprises an acceptable biomarker reading at a single point in time recorded upon compliance with adherence criteria, determining a biomarker sampling parameter from each sampling set, comparing the biomarker sampling parameter to a target biomarker range, calculating an insulin adjustment parameter associated with the biomarker sampling parameter if the biomarker sampling parameter falls outside the target biomarker range, adjusting the insulin dosage by the insulin adjustment parameter if the biomarker sampling parameter falls outside the target biomarker range and if the insulin dosage does not exceed maximum dosage, and exiting the testing method if the adjusted insulin dosage is optimized. The insulin dosage is optimized when one or more biomarker sampling parameters fall within a target biomarker range.

6. 发明申请

US20130212381A1 SYSTEM AND METHOD FOR CONTROLLING AUTHORIZED ACCESS TO A STRUCTURED TESTING PROCEDURE ON A MEDICAL DEVICE 审中-公开
标题翻译：用于控制被授权访问医疗设备上的结构化测试程序的系统和方法
公开(公告)号：US20130212381A1
公开(公告)日：2013-08-15
申请号：US13397241
申请日：2012-02-15
申请人： Steven A. Bousamra , Douglas M. Charboneau , Daniel J. DiSalvo , Alan M. Greenburg , Ulrich Porsch , John F. Price , Raymond A. Strickland , William T. Tucek , Stefan Weinert
发明人： Steven A. Bousamra , Douglas M. Charboneau , Daniel J. DiSalvo , Alan M. Greenburg , Ulrich Porsch , John F. Price , Raymond A. Strickland , William T. Tucek , Stefan Weinert
IPC分类号： G06F21/22
CPC分类号： G06F21/335 , G06F21/6218 , G06F21/629 , G06F2221/2105 , G06F2221/2141 , H04L63/0823 , H04L67/12 , H04L67/34
摘要： Methods and systems for authorizing access to a medical device are disclosed. The methods and systems use authorization certificates to allow and prevent access to one or more operations of the medical device. The methods and systems also allow the tracking of changes made to the medical device by an authorized user.
摘要翻译：公开了授权访问医疗设备的方法和系统。方法和系统使用授权证书来允许和阻止访问医疗设备的一个或多个操作。方法和系统还允许跟踪由授权用户对医疗设备进行的改变。

7. 发明授权

US08667293B2 Cryptographic data distribution and revocation for handheld medical devices 有权
标题翻译：手持医疗设备的加密数据分发和撤销
公开(公告)号：US08667293B2
公开(公告)日：2014-03-04
申请号：US13207934
申请日：2011-08-11
申请人： Daniel Birtwhistle , James Tenbarge , Ulrich Porsch , Kai-Oliver Schwenker , Eric Rachner
发明人： Daniel Birtwhistle , James Tenbarge , Ulrich Porsch , Kai-Oliver Schwenker , Eric Rachner
IPC分类号： G06F21/00
CPC分类号： H04L63/0823 , G06F19/00 , G16H40/40 , H04L9/3268 , H04W12/08 , H04W88/02
摘要： A method includes: receiving a revocation list from a remote data server at a configuration device. The revocation list includes N cryptographic certificates associated with N computer software entities, respectively, that are not to be executed by any of a group of medical devices including a handheld medical device. N is an integer greater than or equal to zero The method further includes receiving data from the handheld medical device at the configuration device. The data includes a cryptographic certificate that is associated with a given computer software entity that is presently installed in memory of the handheld medical device for execution by the handheld medical device. The method further includes comparing the cryptographic certificate with the revocation list; and selectively executing a protective function by the configuration device when the cryptographic certificate is the same as one of the N cryptographic certificates of the revocation list.
摘要翻译：一种方法包括：在配置设备处从远程数据服务器接收撤销列表。撤销列表分别包括与N个计算机软件实体相关联的N个加密证书，其不被包括手持医疗设备的一组医疗设备中的任何一个执行。 N是大于或等于零的整数。该方法还包括在配置设备处从手持式医疗设备接收数据。数据包括与当前安装在手持式医疗设备的存储器中以由手持医疗设备执行的给定计算机软件实体相关联的加密证书。该方法还包括将加密证书与撤销列表进行比较; 并且当密码证书与撤销列表的N个密码证书中的一个相同时，由配置设备选择性地执行保护功能。

8. 发明申请

US20120269347A1 Medical device with secure data transmission 有权
标题翻译：具有安全数据传输的医疗设备
公开(公告)号：US20120269347A1
公开(公告)日：2012-10-25
申请号：US13434298
申请日：2012-03-29
申请人： Ulrich Porsch , Kai-Oliver Schwenker , Daniel Birtwhistle , Raymond Strickland , Max Moser , Thorsten Schroeder
发明人： Ulrich Porsch , Kai-Oliver Schwenker , Daniel Birtwhistle , Raymond Strickland , Max Moser , Thorsten Schroeder
IPC分类号： H04L9/00
CPC分类号： H04L63/0428 , H04L63/061 , H04L63/18 , H04L2463/061 , H04W72/02 , H04W76/10
摘要： Secure transmission of electronic data via a data communication link is provided between a device and an additional device with independent transmission channels, wherein at least one of the devices is a medical device. Secure transmission comprises the following steps or means: providing a password in the device, receiving the password in the a additional device separate from the data communication link, selecting one of the independent transmission channels, encrypting the channel identification of the selected independent transmission channel using the received password in the additional device, transmitting the encrypted channel identification from the additional device to the device via the data communication link and decrypting the encrypted channel identification in the device, providing a session key in the device and the additional device and transmitting encrypted electronic data between the device and the additional device via the independent transmission channel.
摘要翻译：在设备和具有独立传输信道的附加设备之间提供经由数据通信链路的电子数据的安全传输，其中至少一个设备是医疗设备。安全传输包括以下步骤或手段：在设备中提供密码，在与数据通信链路分离的附加设备中接收密码，选择独立传输信道中的一个，加密所选独立传输信道的信道标识，使用在附加设备中接收的密码，经由数据通信链路将加密的信道标识从附加设备发送到设备，并解密设备中的加密信道标识，在设备和附加设备中提供会话密钥，并发送加密电子通过独立传输通道在设备和附加设备之间的数据。

9. 发明申请

US20120094370A1 BLOOD GLUCOSE TEST INSTRUMENT KIT HAVING MODULAR COMPONENT PARTS 有权
标题翻译：具有模块化部件的血液葡萄糖测试仪器套件
公开(公告)号：US20120094370A1
公开(公告)日：2012-04-19
申请号：US12905485
申请日：2010-10-15
申请人： Blaine E. Ramey , Karl Werner , Richard W. Wilson , Christian Niesporek , Ralf Schmitz , Peter Seelig , Kai-Oliver Schwenker , Ulrich Porsch
发明人： Blaine E. Ramey , Karl Werner , Richard W. Wilson , Christian Niesporek , Ralf Schmitz , Peter Seelig , Kai-Oliver Schwenker , Ulrich Porsch
IPC分类号： C12M1/34
CPC分类号： A61B5/14532 , A61B5/150022 , A61B5/150305 , A61B5/150358 , A61B5/150854 , A61B5/150862 , A61B5/15087 , A61B5/150877 , A61B5/150961 , A61B5/155 , A61B5/157 , A61B5/4839 , A61B2560/0443 , A61B2560/045 , A61M5/1723 , G06F19/00 , G16H40/63
摘要： A blood glucose test instrument kit having modular component parts capable of being assembled into a plurality of different handheld blood glucose test instruments is disclosed. The kit comprises the combination of an interconnection platform adapted to connect to a collection of interoperable modules. The collection of interoperable modules including: a plurality of different measurement engine modules, at least one user interface module, at least one power supply module. A handheld blood glucose test instrument is assembled by the interconnection to the interconnection platform of at least one measurement engine module, at least one user interface module, and at least one power supply module. The inter-module communication among the modules connected thereto to achieve enhanced glucose test instrument reliability by effecting at least one reliability protocol selected from a group of reliability protocols.
摘要翻译：公开了具有能够组装成多个不同的手持式血糖测试仪器的模块化部件的血糖测试仪器套件。该套件包括适于连接到可互操作模块集合的互连平台的组合。可互操作模块的集合包括：多个不同的测量引擎模块，至少一个用户界面模块，至少一个电源模块。通过与至少一个测量引擎模块，至少一个用户接口模块和至少一个电源模块的互连平台的互连来组装手持血糖测试仪器。通过实现从一组可靠性协议中选择的至少一个可靠性协议，连接到其上的模块之间的模块间通信实现增强的葡萄糖测试仪器的可靠性。

10. 发明申请

US20130042117A1 CRYPTOGRAPHIC DATA DISTRIBUTION AND REVOCATION FOR HANDHELD MEDICAL DEVICES 有权
标题翻译：手术医疗器械的CRYPTOGRAPHIC数据分配和撤销
公开(公告)号：US20130042117A1
公开(公告)日：2013-02-14
申请号：US13207934
申请日：2011-08-11
申请人： Daniel Birtwhistle , James Tenbarge , Ulrich Porsch , Kai-Oliver Schwenker , Eric Rachner
发明人： Daniel Birtwhistle , James Tenbarge , Ulrich Porsch , Kai-Oliver Schwenker , Eric Rachner
IPC分类号： G06F21/20
CPC分类号： H04L63/0823 , G06F19/00 , G16H40/40 , H04L9/3268 , H04W12/08 , H04W88/02
摘要： A method includes: receiving a revocation list from a remote data server at a configuration device. The revocation list includes N cryptographic certificates associated with N computer software entities, respectively, that are not to be executed by any of a group of medical devices including a handheld medical device. N is an integer greater than or equal to zero The method further includes receiving data from the handheld medical device at the configuration device. The data includes a cryptographic certificate that is associated with a given computer software entity that is presently installed in memory of the handheld medical device for execution by the handheld medical device. The method further includes comparing the cryptographic certificate with the revocation list; and selectively executing a protective function by the configuration device when the cryptographic certificate is the same as one of the N cryptographic certificates of the revocation list.
摘要翻译：一种方法包括：在配置设备处从远程数据服务器接收撤销列表。撤销列表分别包括与N个计算机软件实体相关联的N个加密证书，其不被包括手持医疗设备的一组医疗设备中的任何一个执行。 N是大于或等于零的整数。该方法还包括在配置设备处从手持式医疗设备接收数据。数据包括与当前安装在手持式医疗设备的存储器中以由手持医疗设备执行的给定计算机软件实体相关联的加密证书。该方法还包括将加密证书与撤销列表进行比较; 并且当密码证书与撤销列表的N个密码证书中的一个相同时，由配置设备选择性地执行保护功能。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式